脾切除术
遗传性球形红细胞增多症
球形红细胞增多
表型
医学
基因型
胃肠病学
溶血性贫血
内科学
免疫学
儿科
遗传学
生物
脾脏
基因
作者
Soumitra Tole,Priya Dhir,Jakob Pugi,Luke Drury,Sheila Butchart,Michelle Fantauzzi,Jacob C. Langer,Jillian M. Baker,Victor S. Blanchette,Melanie Kirby‐Allen,Manuel Carção
摘要
Summary Hereditary spherocytosis (HS) is a common inherited haemolytic anaemia attributed to disturbances in five different red cell membrane proteins. We performed a retrospective study of 166 children with HS and describe the clinical phenotype according to the genotype. In 160/166 (97%) children with HS a disease‐causing mutation was identified. Pathogenic variants in ANK1 , SPTB , SLC4A1 and SPTA1 were found in 49%, 33%, 13% and 5% of patients. Children with SLC4A1 ‐HS had the mildest phenotype, showing the highest haemoglobin ( P < 0·001), lowest reticulocyte counts ( P < 0·001) and lowest unconjugated bilirubin levels ( P = 0·006), and none required splenectomy in childhood ( P < 0·001). Conversely, children with autosomal recessive SPTA1 ‐HS had the most severe clinical phenotype, with almost all patients undergoing splenectomy in early childhood. Patients with ANK1 and SPTB variants showed a similar clinical phenotype. Within each gene, variant type or location did not predict disease severity or likelihood of splenectomy. Among patients with a genetic diagnosis, 47 (29%) underwent splenectomy (23 partial; 24 total) while 57 (36%) underwent cholecystectomy. Total splenectomy led to greater improvements in haemoglobin ( P = 0·02). Select use of genetic testing (especially in patients without a family history) may help predict clinical phenotype in childhood and guide family counselling.
科研通智能强力驱动
Strongly Powered by AbleSci AI